Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc. (APDN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
apdn · pe ratio · data through Sep 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Applied DNA Sciences, Inc. (APDN) measures how much investors pay for each dollar of the company's trailing earnings. APDN's current PE ratio of N/A is calculated by dividing its stock price of $5.62 by its TTM earnings per share of -$3.54.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-09-30
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Applied DNA Sciences, Inc.You APDN | $7M | N/A | — | -$3.54 |
 Affimed N.V. AFMD | $3M | N/A | — | -$7.09 |
 Aravive, Inc. ARAV | $3M | N/A | — | -$2.22 |
 Aspira Women's Health Inc. AWH | $2M | N/A | — | -$0.37 |
 Biophytis S.A. BPTS | $3M | N/A | — | -$12.55 |
 DermTech, Inc. DMTKQ | $0M | N/A | — | -$3.09 |
 MedAvail Holdings, Inc. MDVL | $3M | N/A | — | -$36.20 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-09-30Latest FY2025 | — | $-134.23 | — | |
2024-09-30 FY2024 | — | $-1.76 | — | |
2023-09-30 FY2023 | — | $-15.21 | — | |
2022-09-30 FY2022 | — | $-18.68 | — | |
2021-09-30 FY2021 | — | $-46.35 | — | |
2020-09-30 FY2020 | — | $-65.14 | — | |
2019-09-30 FY2019 | — | $-187.30 | — | |
2018-09-30 FY2018 | — | $-317.12 | — | |
2017-09-30 FY2017 | — | $-389.88 | — | |
2016-09-30 FY2016 | — | $-411.13 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Applied DNA Sciences, Inc. (APDN) measures how much investors pay for each dollar of the company's trailing earnings. APDN's current PE ratio of N/A is calculated by dividing its stock price of $5.62 by its TTM earnings per share of -$3.54.
Frequently asked questions
APDN pe ratio · 6 questionsAPDN's current PE ratio is N/A as of 2026-06-09, based on a stock price of $5.62 and TTM EPS of -$3.54. Data sourced from Financial Modeling Prep via APDN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Applied DNA Sciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09